A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

NCT04235621 · clinicaltrials.gov ↗

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision for administrative reasons

Conditions

Glomerulosclerosis, Focal Segmental
Minimal Change Disease
Diabetic Nephropathies

Interventions

OTHER: FSGS/TR-MCD
OTHER: Diabetic Nephropathy (DN)

Sponsor

Goldfinch Bio, Inc.